par Shah, Jatin;Shacham, Sharon;Kauffman, Michael;Daniele, Patrick;Tomaras, Dimitrios;Tremblay, Gabriel;Casasnovas, René Olivier;Maerevoet, Marie
;Zijlstra, Josée J.M.;Follows, George;P Vermaat, Joost J.S.;Kalakonda, Nagesh;Goy, Andre;Choquet, Sylvain;Den Neste, Eric Van;Hill, Brian;Thieblemont, Catherine;Cavallo, Federica;La Cruz, Fátima De;Kuruvilla, John;Hamad, Nada;Bouabdallah, Reda;Jäger, Ulrich;Caimi, Paolo;Gurion, Ronit;Warzocha, Krzysztof;Bakhshi, Sameer;Sancho, Juan Manuel;Schuster, Michael;Egyed, Miklos;Offner, Fritz;Vasilakopoulos, Theodoros T.P.;Samal, Priyanka;Nagy, Agnes;Ku, Matthew;Canales Albendea, Miguel Ángel
Référence Future oncology, 17, 11, page (1295-1310)
Publication Publié, 2021-04
;Zijlstra, Josée J.M.;Follows, George;P Vermaat, Joost J.S.;Kalakonda, Nagesh;Goy, Andre;Choquet, Sylvain;Den Neste, Eric Van;Hill, Brian;Thieblemont, Catherine;Cavallo, Federica;La Cruz, Fátima De;Kuruvilla, John;Hamad, Nada;Bouabdallah, Reda;Jäger, Ulrich;Caimi, Paolo;Gurion, Ronit;Warzocha, Krzysztof;Bakhshi, Sameer;Sancho, Juan Manuel;Schuster, Michael;Egyed, Miklos;Offner, Fritz;Vasilakopoulos, Theodoros T.P.;Samal, Priyanka;Nagy, Agnes;Ku, Matthew;Canales Albendea, Miguel ÁngelRéférence Future oncology, 17, 11, page (1295-1310)
Publication Publié, 2021-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Shah, Jatin; Shacham, Sharon; Kauffman, Michael; Daniele, Patrick; Tomaras, Dimitrios; Tremblay, Gabriel; Casasnovas, René Olivier; Maerevoet, Marie; Zijlstra, Josée J.M.; Follows, George; P Vermaat, Joost J.S.; Kalakonda, Nagesh; Goy, Andre; Choquet, Sylvain; Den Neste, Eric Van; Hill, Brian; Thieblemont, Catherine; Cavallo, Federica; La Cruz, Fátima De; Kuruvilla, John; Hamad, Nada; Bouabdallah, Reda; Jäger, Ulrich; Caimi, Paolo; Gurion, Ronit; Warzocha, Krzysztof; Bakhshi, Sameer; Sancho, Juan Manuel; Schuster, Michael; Egyed, Miklos; Offner, Fritz; Vasilakopoulos, Theodoros T.P.; Samal, Priyanka; Nagy, Agnes; Ku, Matthew; Canales Albendea, Miguel Ángel |
| Informations sur la publication: | Future oncology, 17, 11, page (1295-1310) |
| Statut de publication: | Publié, 2021-04 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | diffuse large B-cell lymphoma |
| disutility of adverse events | |
| EQ-5D-5L | |
| FACT-Lym | |
| health state utility | |
| health utility | |
| health-related quality of life | |
| patient-reported outcomes | |
| selinexor | |
| Note générale: | SCOPUS: re.j |
| DecretOANoAutActif | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1479-6694 |
| info:doi/10.2217/fon-2020-0946 | |
| info:scp/85103094087 | |
| info:pmid/33528286 |



